DVA
DaVita Inc.
232.41
1 x 204.71
1 x 234.00
bid
ask
-
3.17
1.35%
83 @ 07:20 PM
229.63 -2.78 (1.20%)
Ytd104.57%
1y62.06%
229.90
day range
236.54
101.00
52 week range
239.64
Open233.93Prev Close235.58Low229.90High236.54Mkt Cap14.73B
Vol771.23KAvg Vol862.05KEPS10.38P/E22.11Forward P/E13.33
Beta0.88Short Ratio5.77Inst. Own52.88%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg197.69200-d Avg147.691yr Est193.71
Earning
DateForEstimateReportedSurprisesurprise %
2026-05-052026-032.412.870.4619.09%
2026-02-022025-123.243.40.164.94%
2025-10-292025-093.292.51-0.78-23.71%
2025-08-052025-062.72.950.259.26%
2025-05-122025-031.7520.2514.29%
2025-02-132024-122.212.240.031.36%
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-09BarclaysUpgradeEqual-WeightEqual-Weight
2026-05-11TD CowenUpgradeHoldHold
2026-05-08Truist SecuritiesUpgradeHoldHold
2026-05-08BarclaysUpgradeEqual-WeightEqual-Weight
2026-05-07UBSUpgradeBuyBuy
2026-05-06Deutsche BankUpgradeHoldBuy
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Holder
DateNameRelationQuantityDescription
2026-05-06ACKERMAN JOELChief Financial Officer132.43KSale
2026-05-14ARWAY PAMELA M.Director26.95KStock Award(Grant)
2025-05-14BERG CHARLES GDirector27.03KStock Award(Grant)
2026-04-30BERKSHIRE HATHAWAY, INC.Beneficial Owner of more than 10% of a Class of Security0.00Sale
2026-03-12BERRY CHRISTOPHER MICHAELOfficer19.64KStock Award(Grant)
2026-05-14HEARTY JAMES OOfficer22.39KSale
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Berkshire Hathaway, Inc30.10M6.91B46.89%
2026-03-30Blackrock Inc.2.77M635.00M4.31%
2026-03-30Vanguard Capital Management LLC2.18M500.38M3.40%
2026-03-30Morgan Stanley1.67M382.37M2.60%
2026-03-30Vanguard Portfolio Management LLC1.48M339.58M2.30%
2026-03-30Invesco Ltd.1.47M336.89M2.29%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-05-30Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF1.09M249.23M1.69%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.07M244.58M1.66%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund848.58K194.76M1.32%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund770.11K176.75M1.20%
2026-05-30NEUBERGER BERMAN EQUITY FUNDS-Neuberger Quality Equity Fund631.69K144.98M0.98%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund490.42K112.56M0.76%
Split
SplitDate
2 : 12013-09-09
1.5 : 12004-06-16
5 : 31997-10-21